151 related articles for article (PubMed ID: 9588557)
1. Excision repair cross-complementing rodent repair deficiency gene 2 expression and chloroethylnitrosourea resistance in human glioma cell lines.
Chen ZP; McQuillan A; Mohr G; Panasci LC
Neurosurgery; 1998 May; 42(5):1112-9. PubMed ID: 9588557
[TBL] [Abstract][Full Text] [Related]
2. Extraneuronal monoamine transporter expression and DNA repair vis-à-vis 2-chloroethyl-3-sarcosinamide-1-nitrosourea cytotoxicity in human tumor cell lines.
Chen ZP; Remack J; Brent TP; Mohr G; Panasci LC
Clin Cancer Res; 1999 Dec; 5(12):4186-90. PubMed ID: 10632359
[TBL] [Abstract][Full Text] [Related]
3. Evidence for nucleotide excision repair as a modifying factor of O6-methylguanine-DNA methyltransferase-mediated innate chloroethylnitrosourea resistance in human tumor cell lines.
Chen ZP; Malapetsa A; McQuillan A; Marcantonio D; Bello V; Mohr G; Remack J; Brent TP; Panasci LC
Mol Pharmacol; 1997 Nov; 52(5):815-20. PubMed ID: 9351972
[TBL] [Abstract][Full Text] [Related]
4. Correlation of chloroethylnitrosourea resistance with ERCC-2 expression in human tumor cell lines as determined by quantitative competitive polymerase chain reaction.
Chen ZP; Malapetsa A; Marcantonio D; Mohr G; Brien S; Panasci LC
Cancer Res; 1996 Jun; 56(11):2475-8. PubMed ID: 8653679
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-à-vis chemotherapy drug cytotoxicity in human glioma.
Chen H; Shao C; Shi H; Mu Y; Sai K; Chen Z
J Neurooncol; 2007 May; 82(3):257-62. PubMed ID: 17151930
[TBL] [Abstract][Full Text] [Related]
6. [Expression of extraneuronal monoamine transporter gene and DNA repair gene vis-à-vis with antitumor efficacy of SarCNU in human tumor xenografts].
Chen Z; Panasci LC; Carter CA
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):122-4. PubMed ID: 11783015
[TBL] [Abstract][Full Text] [Related]
7. Associations between ERCC2 polymorphisms and gliomas.
Caggana M; Kilgallen J; Conroy JM; Wiencke JK; Kelsey KT; Miike R; Chen P; Wrensch MR
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):355-60. PubMed ID: 11319176
[TBL] [Abstract][Full Text] [Related]
8. Enhancing alkylating agent resistance through ERCC2 gene transfection in human glioma cell line.
Chen Z; Zhang J; Mohr G
Chin Med J (Engl); 2003 Aug; 116(8):1171-4. PubMed ID: 12935404
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of resistance to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) in sensitive and resistant human glioma cells.
Skalski V; Yarosh DB; Batist G; Gros P; Feindel W; Kopriva D; Panasci LC
Mol Pharmacol; 1990 Sep; 38(3):299-305. PubMed ID: 2402223
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of ERCC-2 gene expression in human tumor cell lines by reverse transcription-polymerase chain reaction in comparison to northern blot analysis.
Chen ZP; Malapetsa A; Mohr G; Brien S; Panasci LC
Anal Biochem; 1997 Jan; 244(1):50-4. PubMed ID: 9025907
[TBL] [Abstract][Full Text] [Related]
11. Genomic copy number changes of DNA repair genes ERCC1 and ERCC2 in human gliomas.
Liang BC; Ross DA; Reed E
J Neurooncol; 1995 Oct; 26(1):17-23. PubMed ID: 8583241
[TBL] [Abstract][Full Text] [Related]
12. Enhanced DNA excision repair in CCRF-CEM cells resistant to 1,3-bis(2-chloroethyl)-1-nitrosourea, quantitated using the single cell gel electrophoresis (Comet) assay.
Yamauchi T; Kawai Y; Ueda T
Biochem Pharmacol; 2003 Sep; 66(6):939-46. PubMed ID: 12963480
[TBL] [Abstract][Full Text] [Related]
13. [Effect of pretreatment with N-methyl-N-nitrosourea or streptozotocin on the cytotoxicity and the induction of sister chromatid exchanges in human and rodent brain tumor cells treated with chloroethylnitrosourea].
Tokuda K
Hokkaido Igaku Zasshi; 1992 Jul; 67(4):462-74. PubMed ID: 1427592
[TBL] [Abstract][Full Text] [Related]
14. Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines.
Liang BC
J Neurooncol; 1996 Aug; 29(2):149-55. PubMed ID: 8858520
[TBL] [Abstract][Full Text] [Related]
15. Sequence analysis of the ERCC2 gene regions in human, mouse, and hamster reveals three linked genes.
Lamerdin JE; Stilwagen SA; Ramirez MH; Stubbs L; Carrano AV
Genomics; 1996 Jun; 34(3):399-409. PubMed ID: 8786141
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of cellular resistance to chloroethylnitrosourea in cell lines derived from human brain tumors].
Aida T
Hokkaido Igaku Zasshi; 1988 May; 63(3):348-61. PubMed ID: 3164699
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide excision repair protein levels vis-à-vis anticancer drug resistance in 60 human tumor cell lines.
Chen ZP; Malapetsa A; Monks A; Myers TG; Mohr G; Sausville EA; Scudiero DA; Panasci LC
Ai Zheng; 2002 Mar; 21(3):233-9. PubMed ID: 12451985
[TBL] [Abstract][Full Text] [Related]
18. Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA.
Shou J; Ali-Osman F; Multani AS; Pathak S; Fedi P; Srivenugopal KS
Oncogene; 2002 Jan; 21(6):878-89. PubMed ID: 11840333
[TBL] [Abstract][Full Text] [Related]
19. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
[TBL] [Abstract][Full Text] [Related]
20. Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kinetics.
Noë AJ; Malapetsa A; Panasci LC
Cancer Res; 1994 Mar; 54(6):1491-6. PubMed ID: 8137253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
